Each tablet contains 1.25 mg, 2.5 mg or 5 mg pimobendan
CorMedin Tablets for Dogs are indicated for:
- The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).
- The treatment of preclinical DCM in large breeds. When used in cases of preclinical DCM in large breed dogs, pimobendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes.
- Doberman Pinscher dogs with preclinical DCM treated with pimobendan also demonstrated a significant reduction in Left Ventricular Internal Diameter in both systole and diastole (LVIDs/d) in response to therapy.
|Body-weight (kg)||Pimobendan dosage 0.2 – 0.6 mg / kg daily divided into two treatments given
in the morning and in the evening
|No. of tablets per administration|
|1.25 mg||2.5 mg||5.0 mg||1.25 mg||2.5 mg||5.0 mg|
|5 – 10||1||–||–||1||–||–|
|>10 – 20||–||1||–||–||1||–|
|>20 – 40
(select either row)
|>40 – 60||–||–||2||–||–||2|
|>60 – 80||–||–||3||–||–||3|
|CorMedin 1.25 mg x 84 Tabs||521105|
|CorMedin 2.5 mg x 84 Tabs||521110|
|CorMedin 5 mg x 84 Tabs||521115|